Jazz Seeks Potential Expansion Of Epilepsy Franchise With Saniona Deal

Upfront Fee Seen As Reasonable Investment

 
• By Mandy Jackson
  
SAN2355 will be developed for epilepsy and other neurological disorders (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business